Risk of perioperative mortality and venous thromboembolism after total hip or knee arthroplasty with recent COVID-19 infection: an observational study from the Kaiser Permanente Northern California Database
Acta Orthopaedica · 2025
DOI: 10.2340/17453674.2025.44481 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Acta Orthopaedica, 2025. Verfasst von Aidan T Morrell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Rehabilitation, Oregon Health & Science University, Portland, OR, USA. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, COVID-19, Arthroplasty, Replacement, Hip, Venous Thromboembolism. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background and purpose: Limited data exist on venous thromboembolism (VTE) and mortality risk in patients undergoing primary total hip (THA) or knee arthroplasty (TKA) following recent COVID-19 infection. We aimed to evaluate whether the timing of COVID-19 infection affects postoperative VTE and mortality risk after THA or TKA.
Methods
Adult Kaiser Permanente Northern California members undergoing elective THA or TKA from 2020–2022 were identified using internal procedure codes. 33,520 patients with or without SARS-CoV-2 within 6 months preoperatively were compared. Multivariate Poisson regression was used to calculate incidence rate ratios (RRs) adjusted for demographics, comorbidities, and Covid vaccination status. The primary outcome was 90-day VTE (deep venous thrombosis or pulmonary embolism). The secondary outcome was 90-day mortality.
Results
Among patients with recent COVID-19, the 90-day VTE rate was 0.3%, and the mortality rate was 2.5%. Recent COVID-19 within 6 to 12 weeks preoperatively did not significantly increase 90-day VTE risk (RR 1.0, 95% confidence interval [CI] 0.38–2.8) but was associated with increased 90-day mortality risk (RR 3.1, CI 1.7–5.4).
Conclusion
Recent COVID-19 infection did not significantly impact VTE risk after THA or TKA. However, infection within 6 to 12 weeks preoperatively was associated with increased 90-day mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Orthopedics and Rehabilitation, Oregon Health & Science University, Portland, OR, USA.
- Division of Research, The Permanente Medical Group, Pleasanton, CA, USA.
- Department of Orthopedic Surgery, The Permanente Medical Group, Walnut Creek, CA, USA. John.S.Cox@kp.org.
Zitieren
APA
Morrell, A. T., Kagan, R. P., Kelly, M., DeKeyser, G. J., Avins, A. L., Gigoyan, L. X., & Cox, J. S. (2025). Risk of perioperative mortality and venous thromboembolism after total hip or knee arthroplasty with recent COVID-19 infection: an observational study from the Kaiser Permanente Northern California Database. Acta Orthopaedica. https://doi.org/10.2340/17453674.2025.44481
Vancouver
Morrell AT, Kagan RP, Kelly M, DeKeyser GJ, Avins AL, Gigoyan LX, et al. Risk of perioperative mortality and venous thromboembolism after total hip or knee arthroplasty with recent COVID-19 infection: an observational study from the Kaiser Permanente Northern California Database. Acta Orthopaedica. 2025. doi:10.2340/17453674.2025.44481
BibTeX
@article{Morrell2025,
author = {Morrell, Aidan T and Kagan, Ryland P and Kelly, Mackenzie and DeKeyser, Graham J and Avins, Andrew L and Gigoyan, Lusine X and Cox, John S},
title = {Risk of perioperative mortality and venous thromboembolism after total hip or knee arthroplasty with recent COVID-19 infection: an observational study from the Kaiser Permanente Northern California Database},
journal = {Acta Orthopaedica},
year = {2025},
doi = {10.2340/17453674.2025.44481}
}
EUVIMED